Adar Poonawalla India vaccine Government Adar Poonawalla India

Delays over pricing holds back India’s vital Covid-19 vaccine rollout

Reading now: 447
www.livemint.com

Serum Institute of India Ltd. -- the world’s biggest vaccine maker by volume and AstraZeneca Plc’s local partner -- have engaged in months of haggling behind closed doors and are yet to sign a formal supply agreement.

That has left at least 70 million vaccine doses in limbo despite the urgent need in a country facing the world’s second-largest outbreak.Also Read | The race to take fashion retail onlineOn Sunday, Serum’s billionaire Chief Executive Officer Adar Poonawalla said Indian officials have “orally" agreed to buy 100 million doses at a “special price" of 200 rupees ($2.74) a shot, below the about $4 to $5 price tag given to the U.K.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA